Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
PLoS One ; 16(4): e0250157, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33878138

RESUMEN

The intake of carcinogenic and chemopreventive compounds are important nutritional factors related to the development of malignant tumorous diseases. Repetitive long interspersed element-1 (LINE-1) DNA methylation pattern plays a key role in both carcinogenesis and chemoprevention. In our present in vivo animal model, we examined LINE-1 DNA methylation pattern as potential biomarker in the liver, spleen and kidney of mice consuming green tea (Camellia sinensis) extract (catechins 80%), a chinese bayberry (Morella rubra) extract (myricetin 80%), a flavonoid extract (with added resveratrol) and coffee (Coffee arabica) extract. In the organs examined, carcinogen 7,12-dimethylbenz(a)anthracene (DMBA)-induced hypomethylation was prevented by all test materials except chinese bayberry extract in the kidneys. Moreover, the flavonoid extract caused significant hypermethylation in the liver compared to untreated controls and to other test materials. The tested chemopreventive substances have antioxidant, anti-inflammatory properties and regulate molecular biological signaling pathways. They increase glutathione levels, induce antioxidant enzymes, which decrease free radical damage caused by DMBA, and ultimately, they are able to increase the activity of DNA methyltransferase enzymes. Furthermore, flavonoids in the liver may inhibit the procarcinogen to carcinogen activation of DMBA through the inhibition of CYP1A1 enzyme. At the same time, paradoxically, myricetin can act as a prooxidant as a result of free radical damage, which can explain that it did not prevent hypomethylation in the kidneys. Our results demonstrated that LINE-1 DNA methylation pattern is a useful potential biomarker for detecting and monitoring carcinogenic and chemopreventive effects of dietary compounds.


Asunto(s)
Metilación de ADN/efectos de los fármacos , Elementos de Nucleótido Esparcido Largo/efectos de los fármacos , Extractos Vegetales/farmacología , Animales , Anticarcinógenos/farmacología , Camellia sinensis/efectos de los fármacos , Carcinógenos/farmacología , Catequina/farmacología , Café/química , ADN/metabolismo , Femenino , Flavonoides/farmacología , Glutatión/farmacología , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Elementos de Nucleótido Esparcido Largo/genética , Ratones , Ratones Endogámicos CBA , Myrica/química , Fenoles/farmacología , Polifenoles/farmacología , Bazo/efectos de los fármacos , Té/química , Ácido gamma-Aminobutírico/análogos & derivados
2.
Phytother Res ; 25(4): 493-500, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20799345

RESUMEN

A long-term experimental animal model was developed by our research group for the evaluation of potential chemopreventive effects. The inhibitory effects of agents on carcinogen (7,12-dimethylbenz[a]anthracene (DMBA) induced molecular epidemiological biomarkers, in this case the expression of key onco/suppressor genes were investigated. The expression pattern of c-myc, Ha-ras, Bcl-2, K-ras protooncogene and p53 tumour suppressor gene were studied to elucidate early carcinogenic and potential chemopreventive effects. The consumption of so-called Claw of Dragon tea (CoD™ tea) containing the bark of Uncaria guianensis, Cat's Claw (Uncaria sp. U. tomentosa) and Palmer trumpet-tree (Tabebuia sp. T. avellanedae) was able to decrease the DMBA-induced onco/suppressor gene overexpression in a short-term animal experiment. In a following study CBA/Ca mice were treated with 20 mg/kg bw DMBA intraperitoneally (i.p.) and the expression patterns of onco/suppressor genes were examined at several time intervals. According to the examined gene expression patterns in this long-term experiment the chemopreventive effect of CoD™ tea consumption could be confirmed.


Asunto(s)
Anticarcinógenos/farmacología , Extractos Vegetales/farmacología , Tabebuia/química , Uncaria/química , 9,10-Dimetil-1,2-benzantraceno/antagonistas & inhibidores , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Animales , Femenino , Regulación de la Expresión Génica , Genes Supresores de Tumor , Masculino , Ratones , Ratones Endogámicos CBA
3.
Phytother Res ; 25(2): 221-7, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20641053

RESUMEN

The main bioactive compounds of Trigonella foenum graecum L. (fenugreek) seeds are protodioscin, trigoneoside, diosgenin and yamogenin, which have anticarcinogenic potency through inhibition of cell proliferation and inhibition of prostaglandin synthesis. The effect of fenugreek on ALOX and COX genes was examined in AKR/J H-2(k) mice exposed to dimethylbenz[α]anthracene (DMBA), a potent carcinogen. The expression pattern of these genes was determined by detecting the mRNA expression in various tissues (the lungs, liver, spleen and the kidneys) in four groups of mice. Two groups were fed with normal and two of them with fenugreek containing nutriment. Each group divided into DMBA treated and control groups. Mice were autopsied on day 7 after DMBA treatment for mRNA isolation. Fenugreek consumption itself did not change gene expression compared with the control group. DMBA could increase the expression of ALOX12, ALOX15, ALOX5 genes mainly in all organs. Fenugreek consumption was generally protective in each organ in a different manner. DMBA treatment increased COX2 gene expression, but fenugreek was protective in all tissues examined. In COX1 gene, the fenugreek diet could suppress the expression, except for spleen, independently from carcinogen exposure. Therefore by inhibiting the arachidonic acid metabolism fenugreek may prevent tumorigenesis.


Asunto(s)
Araquidonato Lipooxigenasas/metabolismo , Ciclooxigenasa 1/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Proteínas de la Membrana/metabolismo , Extractos Vegetales/farmacología , Trigonella/química , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Animales , Araquidonato Lipooxigenasas/efectos de los fármacos , Ácido Araquidónico/metabolismo , Carcinógenos/toxicidad , Ciclooxigenasa 1/efectos de los fármacos , Femenino , Riñón/efectos de los fármacos , Riñón/enzimología , Hígado/efectos de los fármacos , Hígado/enzimología , Pulmón/efectos de los fármacos , Pulmón/enzimología , Proteínas de la Membrana/efectos de los fármacos , Ratones , Ratones Endogámicos AKR , Bazo/efectos de los fármacos , Bazo/enzimología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA